Study of TOP1630 for Dry Eye Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This study is designed to assess the efficacy and safety of TOP1630 ophthalmic solution in subjects with Dry Eye Syndrome (DES). Eligible subjects will be randomized double masked to either TOP1630 or placebo for a duration of 28 days' treatment.
Epistemonikos ID: a28943b4252cb92c7b081428dacc8c6a4a11931a
First added on: May 22, 2024